• PDF / 188,569 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 23 Downloads / 171 Views

DOWNLOAD

REPORT

503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860

1

Recommend Documents

Dapagliflozin is cost effective for HF with reduced ejection fraction in China

128 81 164KB

Heart Failure with Reduced Ejection Fraction (HFrEF)

159 16 35MB

Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?

197 65 520KB

Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HF

148 32 545KB

Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction

179 56 749KB

Heart Failure with Preserved Ejection Fraction (HFpEF)

169 39 35MB

Does heart failure with mid-range ejection fraction resemble heart failure with preserved ejection fraction?

157 26 342KB

Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction

153 22 1MB

Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systemat

156 44 2MB

Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicente

134 8 869KB

Ablating the renal nerves to treat heart failure with reduced ejection fraction: another treatment option in a crowded s

161 11 480KB

Cost-Effective

168 109 57MB